Sarah Scofield

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2006

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
November 2006 - October 2011
Lymphoma
Lymphoma, Follicular
Abt-263



